title: Three-dimensional spheroids of adipose-derived mesenchymal stem cells are potent initiators of blood vessel formation in porous polyurethane scaffolds.
abstract: Adipose-derived mesenchymal stem cells (adMSCs) exhibit a high angiogenic activity. Accordingly, their incorporation into tissue constructs represents a promising vascularization strategy in tissue engineering. In the present study, we analyzed whether the efficacy of this approach can be improved by seeding adMSCs as three-dimensional spheroids onto porous scaffolds. Green fluorescent protein (GFP)-positive adMSCs expressing CD13, CD73, CD90 and CD117 were isolated from C57BL/6-TgN(ACTB-EGFP)1Osb/J mice for the generation of spheroids using the liquid overlay technique. Porous polyurethane scaffolds were seeded with these spheroids or a comparable number of individual adMSCs and implanted into the dorsal skinfold chamber of C57BL/6 wild-type mice. The vascularization of the implants was analyzed and compared to non-seeded scaffolds by means of intravital fluorescence microscopy and immunohistochemistry. The adMSC spheroids exhibited a homogeneous diameter of ~270μm and could easily be incorporated into the scaffolds by dynamic seeding. After implantation, they induced a strong angiogenic host tissue response, resulting in an improved scaffold vascularization with a significantly higher functional microvessel density when compared to non-seeded scaffolds and scaffolds seeded with individual adMSCs. Immunohistochemical analyses revealed that a high fraction of ~40% of all microvessels within the center of spheroid-seeded scaffolds developed from GFP-positive adMSCs. These vessels inosculated with ingrowing GFP-negative vessels of the host. This indicates that adMSC spheroids serve as individual vascularization units, promoting the simultaneous development of new microvascular networks at different locations inside implanted tissue constructs. Thus, adMSC spheroids may be used to increase the efficacy of MSC-based vascularization strategies in future tissue engineering applications.
authors: Institute for Clinical & Experimental Surgery, University of Saarland, 66421 Homburg/Saar, Germany. matthias.laschke@uks.eu
authors: M W
authors: MW
authors: Laschke
authors: T E
authors: TE
authors: Schank
authors: C
authors: C
authors: Scheuer
authors: S
authors: S
authors: Kleer
authors: S
authors: S
authors: Schuler
authors: W
authors: W
authors: Metzger
authors: D
authors: D
authors: Eglin
authors: M
authors: M
authors: Alini
authors: M D
authors: MD
authors: Menger
mesh_terms: D017667:Adipocytes / Q000166:cytology* / Q000502:physiology; D000818:Animals; D001808:Blood Vessels / Q000166:cytology* / Q000254:growth & development*; D002454:Cell Differentiation; D002478:Cells, Cultured; D004867:Equipment Design; D019544:Equipment Failure Analysis; D008422:Materials Testing; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D018919:Neovascularization, Physiologic / Q000502:physiology*; D011140:Polyurethanes / Q000737:chemistry; D016062:Porosity; D018874:Spheroids, Cellular / Q000166:cytology / Q000502:physiology; D023822:Tissue Engineering / Q000295:instrumentation; D054457:Tissue Scaffolds
chemical_list: D011140:Polyurethanes